Korsana Biosciences (KRSA) EBT Margin (2019 - 2025)
Korsana Biosciences' EBT Margin came in at -114.97% for Q3 2025, up 466.47 percentage points from -581.44% a year earlier and up 1682.88 percentage points from the prior quarter.
Powered by 
Analysis
Korsana Biosciences (KRSA) EBT Margin (2019 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Korsana Biosciences reported EBT Margin of -127.25%, up 2926.87 percentage points year-over-year; for FY2024, it came in at -181.40%.
- EBT Margin carries a five-year change of +2547.87 percentage points (FY2019 to FY2024).
- Going back by year, EBT Margin was -6242.42% in FY2022 (-4842.25 pp), -1400.18% in FY2021 (+2113.63 pp) and -3513.81% in FY2020 (-784.54 pp).
- The five-year range for quarterly EBT Margin is -21604.84% (Q1 2021) to 27.80% (Q4 2024).
- The fastest year-over-year change in EBT Margin over five years came in Q1 2022 (a gain of 19778.68 percentage points), and the weakest in Q1 2021 (a drop of 19609.97 percentage points).
- Business Quant data shows KRSA's EBT Margin at -1797.85% (Q2 2025), -1798.77% (Q1 2025) and 27.80% (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Korsana Biosciences | 16.27 Mn | 1.82 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -114.97% |
| Jun 30, 2025 | -1,797.85% |
| Mar 31, 2025 | -1,798.77% |
| Dec 31, 2024 | 27.80% |
| Sep 30, 2024 | -581.44% |
| Jun 30, 2022 | -4,389.87% |
| Mar 31, 2022 | -1,826.16% |
| Dec 31, 2021 | -2,690.06% |
| Sep 30, 2021 | -3,242.82% |
| Jun 30, 2021 | -539.20% |
| Mar 31, 2021 | -21,604.84% |
| Dec 31, 2020 | -14,457.14% |
| Sep 30, 2020 | -5,421.75% |
| Jun 30, 2020 | -2,608.01% |
| Mar 31, 2020 | -1,994.87% |
| Dec 31, 2019 | -1,759.28% |
| Sep 30, 2019 | -1,954.01% |
| Jun 30, 2019 | -1,981.20% |
API Access
Korsana Biosciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=KRSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();